Ticagrelor versus prasugrel in patients with high on-clopidogrel treatment platelet reactivity after PCI: The ISAR-ADAPT-PF study.

about

Ticagrelor versus prasugrel in patients with high on-clopidogrel treatment platelet reactivity after PCI: The ISAR-ADAPT-PF study.

Item

http://www.wikidata.org/entity/Q53084647

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Ticagrelor versus prasugrel in ...... PCI: The ISAR-ADAPT-PF study.

@en

Ticagrelor versus prasugrel in ...... PCI: The ISAR-ADAPT-PF study.

@nl

type

Item

label

Ticagrelor versus prasugrel in ...... PCI: The ISAR-ADAPT-PF study.

@en

Ticagrelor versus prasugrel in ...... PCI: The ISAR-ADAPT-PF study.

@nl

prefLabel

Ticagrelor versus prasugrel in ...... PCI: The ISAR-ADAPT-PF study.

@en

Ticagrelor versus prasugrel in ...... PCI: The ISAR-ADAPT-PF study.

@nl

P1476

Ticagrelor versus prasugrel in ...... PCI: The ISAR-ADAPT-PF study.

@en

P2093

Dirk Sibbing

http://www.w3.org/2001/XMLSchema#string

Isabell Bernlochner

http://www.w3.org/2001/XMLSchema#string

Juliane Jaitner

http://www.w3.org/2001/XMLSchema#string

Katharina Mayer

http://www.w3.org/2001/XMLSchema#string

Lisa Gross

http://www.w3.org/2001/XMLSchema#string

Lisa Rössner

http://www.w3.org/2001/XMLSchema#string

Martin Orban

http://www.w3.org/2001/XMLSchema#string

Tanja Morath

http://www.w3.org/2001/XMLSchema#string

P2860

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

Platelet reactivity during ticagrelor maintenance therapy: a patient-level data meta-analysis.

Selective and rapid monitoring of dual platelet inhibition by aspirin and P2Y12 antagonists by using multiple electrode aggregometry.

Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study.

A comparative pharmacodynamic study of ticagrelor versus clopidogrel and ticagrelor in patients undergoing primary percutaneous coronary intervention: the CAPITAL RELOAD study

Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention.

Effect of adenosine A2 receptor stimulation on platelet activation-aggregation: differences between canine and human models.

Bedside evaluation of thienopyridine antiplatelet therapy.

Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.

P304

796-804

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/09537104.2016.1190007

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Adnan Kastrati

Karl-Ludwig Laugwitz

P577

2016-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27275651

http://www.w3.org/2001/XMLSchema#string

P921

clopidogrel